NasdaqGM - Nasdaq Real Time Price USD
Nurix Therapeutics, Inc. (NRIX)
At close: November 5 at 4:00 PM EST
Pre-Market: 7:04 AM EST
Breakdown
TTM
11/30/2023
11/30/2022
11/30/2021
11/30/2020
Operating Cash Flow
-97,144.00
-81,365.00
-159,807.00
-84,365.00
-80.00
Investing Cash Flow
-131,269.00
68,301.00
27,198.00
-108,251.00
-254,404.00
Financing Cash Flow
285,153.00
3,217.00
117,192.00
153,882.00
339,024.00
End Cash Position
99,945.00
55,528.00
65,375.00
80,792.00
119,526.00
Income Tax Paid Supplemental Data
--
--
--
481.00
1.00
Capital Expenditure
-9,753.00
-8,401.00
-12,244.00
-5,661.00
-4,553.00
Issuance of Capital Stock
279,423.00
--
19,400.00
150,157.00
338,061.00
Free Cash Flow
-106,897.00
-89,766.00
-172,051.00
-90,026.00
-4,633.00
11/30/2020 - 7/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYMR Kymera Therapeutics, Inc.
47.69
+1.32%
BCYC Bicycle Therapeutics plc
23.51
+0.21%
ARVN Arvinas, Inc.
26.90
+0.37%
ORIC ORIC Pharmaceuticals, Inc.
9.68
+2.11%
CCCC C4 Therapeutics, Inc.
6.09
-5.58%
KROS Keros Therapeutics, Inc.
62.58
+4.39%
EWTX Edgewise Therapeutics, Inc.
35.94
+4.23%
RVMD Revolution Medicines, Inc.
56.75
+1.58%
AKRO Akero Therapeutics, Inc.
32.74
+2.15%
FHTX Foghorn Therapeutics Inc.
8.94
+8.50%